Dermavant Sciences: Dermavant to Present New Data from Phase

- Patient satisfaction results from tapinarof long-term extension study for the treatment of plaque psoriasis in adults to be presented - Dermavant Sciences, a clinical-stage biopharmaceutical company

Related Keywords

United States , Koloa , Hawaii , America , Sandy Johnson , Paul Yamauchi , Laurence Watts , Annam Tallman , Neal Bhatia , Angela Salerno Robin , Kostenloser Wertpapierhandel , Angelay Moore , Roivant Sciences , Program For Tapinarof , Twitter , Drug Administration , Dermavant Sciences , Linkedin Dermavant Sciences , Clinical Dermatology Conference , New Drug Application , Prescription Drug User Fee Act , Poster Gallery , Grand Promenade , Grand Hyatt Kauai , Patient Satisfaction , Tapinarof Cream , Once Daily , Plaque Psoriasis , Long Term Extension , Patient Satisfaction Questionnaire , Jerry Bagel , Linda Stein Gold , James Del Rosso , North America , Vice President , Media Relations , Dermavant , Ciences , Present , Data , Rom , Hase , Soaring , Program , 022 , Winter , Linical , Ermatology , Conference ,